Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06048419 · ClinicalTrials.gov registry record · NA

Acceptability and Efficacy of GO MOVE

A NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Texas Scottish Rite Hospital for Children.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06048419: Recruiting NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy, sponsored by Texas Scottish Rite Hospital for Children.

NCT06048419 is a NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy that is actively recruiting participants, run by Texas Scottish Rite Hospital for Children. The registered enrollment target is 50 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06048419, a NA study of Cerebral Palsy and Hemiplegic Cerebral Palsy, is actively recruiting participants, sponsored by Texas Scottish Rite Hospital for Children.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn about the acceptability and efficacy of Go Move, a mobile website developed to assist youth with unilateral cerebral palsy and their caregivers with setting goals and selecting exercises and activities to meet the goals. The main question\[s\] it aims to answer are: * Is Go Move accepted by youth with unilateral cerebral palsy and their caregivers? * Does Go Move support goal attainment for youth with unilateral cerebral palsy? Participants will set up and participate in a goal-driven home program using the Go Move mobile website. Participants will spend 1 hour and 15 minutes per week for 6 weeks working on their home program and will complete pre-intervention and post-intervention assessments.

Primary Outcome

The Canadian Occupational Performance Measure is a criterion referenced, individualized, client-centered outcome measure designed for use by occupational therapists to detect change in a client's self-perception of occupational performance over time on a scale of 1-10 (1 being the lowest)

Interventions

  • BEHAVIORAL Home Program

Study Locations (1)

Texas

  • Scottish Rite for Children - Frisco

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-02-20
Est. Completion 2026-12
Phase NA

What NCT06048419 shows while recruiting

NCT06048419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Home Program is the first listed.

NCT06048419 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06048419 about?

NCT06048419 is a clinical study titled "Acceptability and Efficacy of GO MOVE". The goal of this clinical trial is to learn about the acceptability and efficacy of Go Move, a mobile website developed to assist youth with unilateral cerebral palsy and their caregivers with setting goals and selecting exercises and activities to meet the goals. The main question\[s\] it aims to a...

What is the current status of trial NCT06048419?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-02-20. Estimated completion is 2026-12.

What conditions does trial NCT06048419 study?

This clinical trial studies the following conditions: Cerebral Palsy, Hemiplegic Cerebral Palsy.

What interventions are being tested in trial NCT06048419?

The interventions under investigation include: Home Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06048419?

This trial is sponsored by Texas Scottish Rite Hospital for Children, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06048419 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06048419's enrollment target sits among peer trials

50 39th of 91 higher than 52 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06048419, the US trial registry maintained by the National Library of Medicine. NCT06048419 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.